Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.

about

Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way.First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?

P2860

Q48546255-BD49DA5B-C21E-4929-B5DD-33F5DF491DFA Q50073382-437AEB79-7D75-475D-BD5F-19523AEDD24C

P2860

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.

Item

http://www.wikidata.org/entity/Q48352757

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combination of chemotherapy an ...... A randomized controlled trial.

@en

Combination of chemotherapy an ...... A randomized controlled trial.

@nl

type

Item

label

Combination of chemotherapy an ...... A randomized controlled trial.

@en

Combination of chemotherapy an ...... A randomized controlled trial.

@nl

prefLabel

Combination of chemotherapy an ...... A randomized controlled trial.

@en

Combination of chemotherapy an ...... A randomized controlled trial.

@nl

P1476

Combination of chemotherapy an ...... A randomized controlled trial.

@en

P2093

Aiqing Gu

http://www.w3.org/2001/XMLSchema#string

Bo Jin

http://www.w3.org/2001/XMLSchema#string

Chunlei Shi

http://www.w3.org/2001/XMLSchema#string

Hua Zhong

http://www.w3.org/2001/XMLSchema#string

Huimin Wang

http://www.w3.org/2001/XMLSchema#string

Jianlin Xu

http://www.w3.org/2001/XMLSchema#string

Jun Pei

http://www.w3.org/2001/XMLSchema#string

Lei Zhu

http://www.w3.org/2001/XMLSchema#string

Tianqing Chu

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters

Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Global cancer statistics, 2012

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.

P304

1249-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30806

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

Baohui Han

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28560853

http://www.w3.org/2001/XMLSchema#string

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.

about

P2860

P2860

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698